What is Zevra Therapeutics, Inc.'s current ratio?

Zevra Therapeutics, Inc. (ZVRA) reported current ratio of 4.9× in Q1 2026.

How has Zevra Therapeutics, Inc.'s current ratio changed year-over-year?

Zevra Therapeutics, Inc.'s current ratio increased by 61.7% year-over-year, from 3× to 4.9×.

What is the long-term trend for Zevra Therapeutics, Inc.'s current ratio?

Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s current ratio has grown at a 38.5% compound annual growth rate (CAGR), from 1.1× to 5.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Zevra Therapeutics, Inc. ZVRA Current ratio

Current ratio at other companies

BioMarin PharmaceuticalsBMRN

5.8×+0.3×

Ultragenyx PharmaceuticalRARE

2×-0.4×

XER

Xeris Biopharma Holdings, Inc.XERS

2.1×+0.4×

Eton Pharmaceuticals, Inc.ETON

1.2×-0.8×

Theravance BiopharmaTBPH

13.1×+8.4×

Relay Therapeutics, Inc.RLAY

22.1×+2.2×

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Where this comes from

Calculated from Zevra Therapeutics, Inc.’s reported figures.

total current assets/total current liabilities=4.9×

Based on the most recent quarter.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s current ratio?: Zevra Therapeutics, Inc. (ZVRA) reported current ratio of 4.9× in Q1 2026.
How has Zevra Therapeutics, Inc.'s current ratio changed year-over-year?: Zevra Therapeutics, Inc.'s current ratio increased by 61.7% year-over-year, from 3× to 4.9×.
What is the long-term trend for Zevra Therapeutics, Inc.'s current ratio?: Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s current ratio has grown at a 38.5% compound annual growth rate (CAGR), from 1.1× to 5.7×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.